- If you are wondering whether Ensign Group's current share price lines up with its underlying value, you are not alone. This article is here to unpack that question step by step.
- The stock last closed at US$214.23, with returns of 1.7% over 7 days, 24.7% over 30 days, 23.2% year to date, 66.1% over 1 year, 135.6% over 3 years and 167.9% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation.
- Recent coverage of Ensign Group has focused on its position in the US healthcare sector and investor interest in companies linked to long term care and related services. This helps frame how the market is thinking about the stock today. This context is useful as we look at whether the current price simply reflects sentiment or lines up with what different valuation methods suggest.
- On Simply Wall St's 6 point valuation check, Ensign Group currently has a valuation score of 0 out of 6. Next we will walk through the standard valuation approaches that lead to that result, and then finish with a more holistic way to think about what the stock could be worth.
Ensign Group scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Ensign Group Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow model looks at the cash Ensign Group could generate in the future, then discounts those projected cash flows back to what they might be worth in $ today.
For Ensign Group, the latest twelve month Free Cash Flow is about $386.7 million. Using a 2 Stage Free Cash Flow to Equity model, analysts have provided explicit estimates up to 2028, with Simply Wall St extrapolating further out. For example, projected Free Cash Flow is $284.0 million in 2026, $319.1 million in 2027 and $359.7 million in 2028, with additional extrapolated figures out to 2035.
When all of those cash flows are discounted back and combined, the model arrives at an estimated intrinsic value of roughly $148.89 per share. Compared with the recent share price of US$214.23, this implies the stock is 43.9% above the DCF estimate, suggesting it screens as expensive on this cash flow based approach.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Ensign Group may be overvalued by 43.9%. Discover 46 high quality undervalued stocks or create your own screener to find better value opportunities.
Approach 2: Ensign Group Price vs Earnings
For a profitable company like Ensign Group, the P/E ratio is a straightforward way to see what you are paying for each dollar of earnings. Investors usually accept a higher P/E when they expect stronger growth or see the business as lower risk, and a lower P/E when growth expectations are more modest or risks feel higher.
Ensign Group currently trades on a P/E of 35.92x. That sits above the Healthcare industry average P/E of 23.67x and also above the peer average of 18.06x. Simply Wall St’s Fair Ratio for Ensign Group is 27.21x, which reflects what its P/E might look like after adjusting for factors such as earnings growth, profit margins, its Healthcare industry classification, market cap and company specific risks.
The Fair Ratio is more tailored than a simple peer or industry comparison because it aims to align the valuation with Ensign Group’s own characteristics rather than assuming it should trade like an average Healthcare stock. When compared with this 27.21x Fair Ratio, the current 35.92x P/E suggests Ensign Group is trading above that blended reference point.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.
Upgrade Your Decision Making: Choose your Ensign Group Narrative
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way to connect your view of Ensign Group’s story with the numbers behind it.
A Narrative is your own explanation of what you think is happening at the company and where it could go next, paired with your assumed fair value and your expectations for future revenue, earnings and margins.
On Simply Wall St’s Community page, Narratives let you link that story to a financial forecast, then to a fair value, and quickly compare that fair value with the current price. This can help you decide whether Ensign Group looks attractive or stretched on your terms.
Because Narratives on the platform are refreshed when new information such as earnings releases or news is incorporated, your view can stay aligned with the latest data without you rebuilding every assumption from scratch.
For Ensign Group, one investor might see strong long term potential and set a higher fair value, while another might focus on risks and set a lower fair value. Both would be using the same current price as the reference point for their decision.
Do you think there's more to the story for Ensign Group? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com